Depreciation in USD of Chemomab Therapeutics Ltd. from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Chemomab Therapeutics Ltd. quarterly and annual Depreciation history and change rate from 2018 to 2024.
  • Chemomab Therapeutics Ltd. Depreciation for the quarter ending 31 Mar 2023 was $16,000, a 23.1% increase year-over-year.
  • Chemomab Therapeutics Ltd. annual Depreciation for 2024 was $53,000, a 20.9% decline from 2023.
  • Chemomab Therapeutics Ltd. annual Depreciation for 2023 was $67,000, a 15.5% increase from 2022.
  • Chemomab Therapeutics Ltd. annual Depreciation for 2022 was $58,000, a 70.6% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Chemomab Therapeutics Ltd. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $16,000 +$3,000 +23% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q1 2022 $13,000 +$6,000 +86% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $7,000 +$2,000 +40% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $5,000 -$16,000 -76% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q1 2019 $21,000 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1

Chemomab Therapeutics Ltd. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $53,000 -$14,000 -21% 01 Jan 2024 31 Dec 2024 20-F 04 Apr 2025 2024 FY
2023 $67,000 +$9,000 +16% 01 Jan 2023 31 Dec 2023 20-F 04 Apr 2025 2024 FY
2022 $58,000 +$24,000 +71% 01 Jan 2022 31 Dec 2022 20-F 04 Apr 2025 2024 FY
2021 $34,000 +$10,000 +42% 01 Jan 2021 31 Dec 2021 20-F 28 Mar 2024 2023 FY
2020 $24,000 -$257,000 -91% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 $281,000 +$215,000 +326% 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY
2018 $66,000 01 Jan 2018 31 Dec 2018 10-K 17 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.